Erectile dysfunction Board decisions

The Veteran's service-connected PTSD, fibromyalgia, lumbar spine disability, bilateral knee conditions, tinnitus, dermatitis, and erectile dysfunction require regular aid and attendance due to mental health issues. The Board granted special monthly compensation (SMC) based on the need for regular aid and attendance.

The Veteran's prostate cancer and residuals are rated at 20 percent for the period between December 1, 2013, and February 15, 2017. Effective February 15, 2017, he is entitled to a 40 percent rating. His erectile dysfunction secondary to prostate cancer remains noncompensable.

The Board has determined that additional medical opinions are needed to clarify the etiology of the Veteran's PVD and ED, as well as address whether these conditions are related to his service-connected disabilities or exposure to Agent Orange. The TDIU claim is also remanded for further evaluation.

The Board has remanded several issues related to the Veteran's service-connected conditions, including headaches, allergic rhinitis, PTSD, erectile dysfunction, and prostate cancer residuals. The appeals for these issues are pending further development.

The appeal of the issue of entitlement to service connection for sleep apnea is dismissed.,New and material evidence has been received and the petition to reopen a claim of service connection for lumbar spine disability is granted.

The Veteran withdrew his appeals for right eye macular degeneration, erectile dysfunction, and loss of use of the right thumb. The claims are dismissed.

The Board dismissed the appeals for service connection and rating issues, except for a grant of a disability rating in excess of 70 percent for PTSD with other specified depressive disorder.

The Veteran's TDIU and DEA claims are denied as the effective date for both benefits is February 27, 2020.

The Veteran's claims for service connection for diabetes mellitus type II, erectile dysfunction secondary to diabetes mellitus type II, peripheral neuropathy of the bilateral lower extremities, and hypertension are granted due to exposure to herbicide agents during his active duty service. The effective date is October 1, 2026.

The Board has remanded the claims for diabetes mellitus type II, hypertension, erectile dysfunction as secondary to diabetes mellitus type II, and obstructive sleep apnea as secondary to diabetes mellitus type II due to concerns about exposure to chemicals during service.

The Board dismissed the appellant's appeals regarding entitlement to higher evaluations for PTSD and peripheral neuropathy of both lower extremities, as well as earlier effective dates for service connection. The Veteran's disabilities were found not to warrant such adjustments.,The Board also denied the appellant's claims for special monthly compensation based on aid and attendance prior to February 28, 2014, and an increased level of SMC based on need for regular aid and attendance.

The Board has remanded the issues of entitlement to higher ratings for various service-connected conditions, including coronary artery disease and peripheral neuropathy. The Veteran's appeal is not about service connection but rather about the appropriate disability rating.

The Veteran's claims for prostate cancer and erectile dysfunction have been granted. Prostate cancer is presumed due to herbicide exposure under the PACT Act, while erectile dysfunction is secondary to service-connected prostate cancer.,Blood cancer and lung cancer remain pending as they require further examination and opinion regarding their relationship to service.

The Veteran's service connection claims for coronary artery disease, myocardial infarction, coronary artery bypass graft, type II diabetes mellitus, erectile dysfunction, bilateral diabetic peripheral neuropathy of the upper and lower extremities, and bilateral diabetic retinopathy have been granted. These conditions are presumed to be associated with herbicide agent exposure in Guam.

The Veteran's claims for bilateral knee disability, arthritis, bilateral eye condition, headaches, acquired psychiatric disorder, and tremors are denied. The claims for bilateral hearing loss, hypertension, and erectile dysfunction are remanded due to duty-to-assist errors.

The Board has granted service connection for bilateral hearing loss, bilateral tinnitus, vertigo, headaches, and erectile dysfunction (due to herbicide agent exposure) based on the Veteran's credible statements regarding his in-service noise exposure and symptoms.

The Board has remanded four service connection claims: erectile dysfunction, gastrointestinal disorder, GERD with acid reflux, and skin cancer. The remand requires the AOJ to obtain addendum medical opinions addressing the etiology of each condition in relation to the Veteran's service-connected PTSD and any prescribed medications related to his psychiatric disability.

The Board has remanded the case due to new evidence submitted by the Veteran, which was not considered in the previous decisions. The issues of assigning a compensable rating for prostate cancer prior to April 12, 2010 and a disability rating in excess of 40 percent thereafter are being reviewed.

Service connection is granted for a brain condition (other than already service-connected epilepsy) and reopening of service connection for a low back disability. Other claims are remanded.

The Board has dismissed the appeals for issues related to effective dates and service connection, as the Veteran withdrew his appeals. The remaining claims of service connection have been remanded.